Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000659.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 15.99 0.24 0.20
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 449.76 167.49 -30.47
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.66 0.25 0.25
Cash 69.47 0.03 0.02
Capex -5.70 -0.01 -0.01
Free Cash Flow -67.65 < 0.005 0.03
Revenue 29.18 0.18 0.14
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 258.22 0.16 -0.04
Operating Margin 96.76 -0.02 -0.54
ROA 90.91 < 0.005 -0.06
ROE 90.51 -0.03 -0.32
ROIC 93.09 < 0.005 -0.08
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000659.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000659.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000659.SZ is permitted for members.